Auriga implements new sales force initiative
Auriga is among the first pharmaceutical companies to apply a commission-only structure. While many pharmaceutical companies compensate sales employees with an estimated 70% salary and the remainder in
The European Commission (EC) has approved an extended use of Johnson & Johnson’s Tecvayli (teclistamab), along with daratumumab, to treat adult patients with relapsed or refractory multiple myeloma (r/r MM).